Coombes RC, Tovey H, Kilburn L, et al. A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT – Randomised EuropeAn celecoxib trial). SABCS 2017, GS3-03.
Eerste studie naar neoadjuvante immuuntherapie bij PCC van start
apr 2021 | Dermato-oncologie, Immuuntherapie